一本关于表单结构和策略的入门书
1Cencora, Conshohocken, PA.
Journal of managed care & specialty pharmacy
|February 3, 2024
概括
配方产品通过指导治疗选择来管理医疗保健成本并改善患者的治疗结果. 不断发展的战略适应新产品和健康公平目标,确保可持续的管理护理药房.
科学领域:
- 医疗保健服务研究 医疗服务研究
- 制药政策 制药政策
- 管理护理药房 管理护理药房
背景情况:
- 配方制品是管理医疗保健成本,优化患者获取药物的必不可少的工具,并提高整体健康结果.
- 它们旨在平衡适当的治疗准入与有效的资源利用,以实现可持续的托管护理业务.
- 传统的配方模型包括开放式,封闭式和分层结构,而新的方法强调产品价值.
研究的目的:
- 审查配方药在管理护理药房中的作用和演变.
- 确定表单开发和定制中的关键驱动因素和考虑因素.
- 探索影响未来表单策略的新兴趋势.
主要方法:
- 审查现有的表单策略和管理原则.
- 分析影响表单设计的因素,包括会员群体和监管要求.
- 讨论新药品和健康趋势对配方管理的影响.
主要成果:
- 配方剂对于管理护理组织来说仍然至关重要,特别是高成本和专用药物的普及率越来越高.
- 定制表单开发受到区域需求和福利设计等多种因素的影响.
- 配方开发过程由药品和治疗 (P&T) 和价值委员会指导.
结论:
- 配方产品是动态的工具,需要不断适应市场变化和医疗保健优先事项.
- 未来的配方药策略将由生物类似药,数字治疗等创新塑造,并专注于健康公平.
- 有效的表单管理对于实现成本效益和管理护理环境中最佳的患者护理至关重要.
相关概念视频
Prescription, Nonprescription and Orphan Drugs
733
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
733
Structure-Activity Relationships and Drug Design
721
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
721
Insulin Formulations: Types and Delivery
197
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
197
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K
Biopharmaceutics and Pharmacokinetics: Overview
2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K
Factors Influencing Drug Absorption: Presystemic Elimination
219
The pharmacokinetic journey of oral drugs begins with a crucial first pass through the hepatic portal system, called the first-pass effect. This first pass significantly impacts bioavailability — the proportion of a drug that enters systemic circulation and is available for therapeutic action. The primary route sees the drug absorbed by intestinal membranes and then shunted to the liver via the hepatic portal vein. Here, pre-systemic elimination occurs as drugs face metabolism or biliary...
219


